Cabio Biotech (Wuhan) Co (SHSE:688089) Institutional Ownership: 1.48% (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688089 Cabio Biotech (Wuhan) Co Ltd SHSE:688089
75 GF Score
Price ¥8.45
GF Value ¥12.10
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Cabio Biotech (Wuhan) Co Institutional Ownership?

Cabio Biotech (Wuhan) Co SHSE:688089 +1.68% 75 Institutional Ownership is 1.48% as of Sep. 01, 2026. GuruFocus rates SHSE:688089 with a GF Score™ of 75/100 and a GF Value™ of ¥12.10 (Possible Value Trap). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cabio Biotech (Wuhan) Co's institutional ownership is 1.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cabio Biotech (Wuhan) Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cabio Biotech (Wuhan) Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Cabio Biotech (Wuhan) Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Cabio Biotech (Wuhan) Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabio Biotech (Wuhan) Co Institutional Ownership Chart

Cabio Biotech (Wuhan) Co Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 5.37 5.37 1.70 1.70 1.70 1.70 1.48 1.48 1.48 1.48
SHSE:688089
75GF Score
Cabio Biotech (Wuhan) Co Ltd SHSE:688089
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabio Biotech (Wuhan) Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.48% mean?
Cabio Biotech (Wuhan) Co (SHSE:688089) has a Institutional Ownership of 1.48% as of Sep. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cabio Biotech (Wuhan) Co and its competitors.
Is Cabio Biotech (Wuhan) Co's Institutional Ownership too high?
Cabio Biotech (Wuhan) Co's current Institutional Ownership is 1.48%. Overall, Cabio Biotech (Wuhan) Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cabio Biotech (Wuhan) Co's Institutional Ownership compare to VRTX and REGN?
Cabio Biotech (Wuhan) Co's Institutional Ownership of 1.48% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cabio Biotech (Wuhan) Co and its competitors. Cabio Biotech (Wuhan) Co's current Institutional Ownership is 1.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabio Biotech (Wuhan) Co stock overvalued right now?
Based on GuruFocus' analysis, Cabio Biotech (Wuhan) Co (SHSE:688089) is currently considered Possible Value Trap. The stock's GF Value™ is ¥12.10, compared to a current price of ¥8.45 — trading 30.2% below its estimated fair value. The current Institutional Ownership is 1.48%. Cabio Biotech (Wuhan) Co's overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Cabio Biotech (Wuhan) Co (SHSE:688089), the current Institutional Ownership is 1.48% as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabio Biotech (Wuhan) Co (SHSE:688089) Overvalued in 2026?

Based on GuruFocus' analysis, Cabio Biotech (Wuhan) Co stock appears to be undervalued. The current stock price of ¥8.45 is trading 30.2% below its estimated GF Value™ of ¥12.10. GuruFocus considers Cabio Biotech (Wuhan) Co to be Possible Value Trap.

Key valuation signals for SHSE:688089:

  • Institutional Ownership: 1.48%
  • GF Value™: ¥12.10 vs. price of ¥8.45 (30.2% below fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the SHSE:688089 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabio Biotech (Wuhan) Co Business Description

Address No. 999, Gaoxin Avenue, East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430075
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
75GF Score

Get the complete analysis for SHSE:688089

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.45
Price
¥12.10
GF Value